Recent advances in the management of pulmonary arterial hypertension [version 1; referees: 2 approved]
Over the past 20 years, there has been an explosion in the development of therapeutics to treat pulmonary arterial hypertension (PAH), a rare but life-threatening disorder associated with progressive elevation of pulmonary pressures and severe right heart failure. Recently, the field has seen the in...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2016-11-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/5-2755/v1 |